TCON logo

TRACON Pharmaceuticals (TCON) Cash From Investing

Annual CFI

$0.00
+$17.00 K+100.00%

December 31, 2023

Summary

Performance

1-Year Change

+100%

3-Year Change

+100%

5-Year Change

+100%

15-Year Change

-100%

TCON Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

67.76%
TCON annual cash flow from investing activities is higher than 67.76% of companies in Healthcare sector

High & Low

All-time High

$14.02 M
TCON annual cash flow from investing activities is currently -100.00% below its historical high of $14.02 million

3-Year Low

-$17.00 K

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
TCON previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 7, 2025
TCON next annual earnings announcement is scheduled for Feb 7, 2025

OtherTCONcash flowmetrics:

Annual CFF

-$12.54 M
TCON annual cash flow from financing activities is -$12.54 million

Annual CFO

$3.68 M
TCON annual cash flow from operations is $3.68 million

Annual FCF

$3.68 M
TCON annual free cash flow is $3.68 million

Annual CAPEX

-
TCON annual capital expenditures value is unknown

Quarterly CFI

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

TCON Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.00 M
TCON quarterly cash flow from investing activities is currently at an all-time high

3-Year Low

-$9000.00
TCON quarterly cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
TCON previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
TCON next earnings announcement is scheduled for Feb 7, 2025

OtherTCONcash flowmetrics:

Quarterly CFF

$1.15 M
TCON quarterly cash flow from financing activities is $1.15 million

Quarterly CFO

-$2.77 M
TCON quarterly cash flow from operations is -$2.77 million

Quarterly FCF

-$2.77 M
TCON quarterly free cash flow is -$2.77 million

Quarterly CAPEX

-
TCON quarterly capital expenditures value is unknown

TTM CFI

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

TCON TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$19.07 M
TCON TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-$24.00 K
TCON TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
TCON previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
TCON next earnings announcement is scheduled for Feb 7, 2025

OtherTCONcash flowmetrics:

TTM CFF

-$4.75 M
TCON TTM cash flow from financing activities is -$4.75 million

TTM CFO

$9.22 M
TCON TTM cash flow from operations is $9.22 million

TTM FCF

$9.22 M
TCON TTM free cash flow is $9.22 million

TTM CAPEX

-
TCON TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TCON Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.0%--
3 y3 years+100.0%--
5 y5 years+100.0%--

TCON Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%+100.0%
5 y5-year-100.0%+100.0%
alltimeall time-100.0%+100.0%

TRACON Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2023
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 2023
-
$0.00(-100.0%)
-$4000.00(-76.5%)
Dec 2022
-$17.00 K(-100.4%)
-$4000.00(-42.9%)
-$17.00 K(-22.7%)
Sep 2022
-
-$7000.00(+250.0%)
-$22.00 K(-8.3%)
Jun 2022
-
-$2000.00(-50.0%)
-$24.00 K(-100.6%)
Mar 2022
-
-$4000.00(-55.6%)
$3.95 M(0.0%)
Dec 2021
$3.95 M(-198.7%)
-$9000.00(0.0%)
$3.95 M(-9509.5%)
Sep 2021
-
-$9000.00(-100.2%)
-$42.00 K(+27.3%)
Jun 2021
-
$3.97 M(<-9900.0%)
-$33.00 K(-99.2%)
Mar 2021
-
-$4000.00(-99.9%)
-$4.01 M(+0.1%)
Dec 2020
-$4.00 M(-128.6%)
-$4.00 M(<-9900.0%)
-$4.00 M(<-9900.0%)
Sep 2020
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2020
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2020
-
$0.00(0.0%)
$10.00 M(-28.7%)
Dec 2019
$14.02 M(-258.1%)
$0.00(0.0%)
$14.02 M(-26.5%)
Sep 2019
-
$0.00(-100.0%)
$19.07 M(0.0%)
Jun 2019
-
$10.00 M(+148.8%)
$19.07 M(-293.7%)
Mar 2019
-
$4.02 M(-20.5%)
-$9.85 M(+11.0%)
Dec 2018
-$8.87 M
$5.05 M(>+9900.0%)
-$8.87 M(-44.3%)
DateAnnualQuarterlyTTM
Sep 2018
-
$0.00(-100.0%)
-$15.93 M(+23.1%)
Jun 2018
-
-$18.92 M(-478.5%)
-$12.94 M(-389.1%)
Mar 2018
-
$5.00 M(-349.1%)
$4.47 M(+21.8%)
Dec 2017
$3.67 M(+77.2%)
-$2.01 M(-167.0%)
$3.67 M(+50.5%)
Sep 2017
-
$2.99 M(-297.9%)
$2.44 M(-162.9%)
Jun 2017
-
-$1.51 M(-136.0%)
-$3.88 M(+70.2%)
Mar 2017
-
$4.20 M(-229.7%)
-$2.28 M(-210.0%)
Dec 2016
$2.07 M(-119.0%)
-$3.24 M(-2.7%)
$2.07 M(-58.3%)
Sep 2016
-
-$3.33 M(-3883.0%)
$4.98 M(-325.0%)
Jun 2016
-
$88.00 K(-99.0%)
-$2.21 M(-6.4%)
Mar 2016
-
$8.55 M(-2653.1%)
-$2.36 M(-78.4%)
Dec 2015
-$10.92 M(>+9900.0%)
-$335.00 K(-96.8%)
-$10.92 M(+2.9%)
Sep 2015
-
-$10.52 M(>+9900.0%)
-$10.61 M(+9207.9%)
Jun 2015
-
-$62.00 K(+3000.0%)
-$114.00 K(+58.3%)
Mar 2015
-
-$2000.00(-93.1%)
-$72.00 K(+2.9%)
Dec 2014
-$70.00 K(+900.0%)
-$29.00 K(+38.1%)
-$70.00 K(+70.7%)
Sep 2014
-
-$21.00 K(+5.0%)
-$41.00 K(+105.0%)
Jun 2014
-
-$20.00 K
-$20.00 K
Dec 2013
-$7000.00(-30.0%)
-
-
Dec 2012
-$10.00 K
-
-

FAQ

  • What is TRACON Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for TRACON Pharmaceuticals?
  • What is TRACON Pharmaceuticals annual CFI year-on-year change?
  • What is the all time high quarterly CFI for TRACON Pharmaceuticals?
  • What is the all time high TTM CFI for TRACON Pharmaceuticals?

What is TRACON Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of TCON is $0.00

What is the all time high annual CFI for TRACON Pharmaceuticals?

TRACON Pharmaceuticals all-time high annual cash flow from investing activities is $14.02 M

What is TRACON Pharmaceuticals annual CFI year-on-year change?

Over the past year, TCON annual cash flow from investing activities has changed by +$17.00 K (+100.00%)

What is the all time high quarterly CFI for TRACON Pharmaceuticals?

TRACON Pharmaceuticals all-time high quarterly cash flow from investing activities is $10.00 M

What is the all time high TTM CFI for TRACON Pharmaceuticals?

TRACON Pharmaceuticals all-time high TTM cash flow from investing activities is $19.07 M